Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 1864107, 14 pages
https://doi.org/10.1155/2018/1864107
Research Article

Glucagon-Like Peptide-1 Mediates the Protective Effect of the Dipeptidyl Peptidase IV Inhibitor on Renal Fibrosis via Reducing the Phenotypic Conversion of Renal Microvascular Cells in Monocrotaline-Treated Rats

1Department of Respiratory & Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China
2Department of Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China

Correspondence should be addressed to Hong Wang; nc.ude.umjn@gnawgnoh and Xiangrong Zuo; moc.liamg@ouzgnorgnaix

Received 21 June 2017; Revised 24 November 2017; Accepted 4 December 2017; Published 23 January 2018

Academic Editor: Bo Zuo

Copyright © 2018 Jian Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jian Xu, Jingjing Wang, Yusheng Cheng, et al., “Glucagon-Like Peptide-1 Mediates the Protective Effect of the Dipeptidyl Peptidase IV Inhibitor on Renal Fibrosis via Reducing the Phenotypic Conversion of Renal Microvascular Cells in Monocrotaline-Treated Rats,” BioMed Research International, vol. 2018, Article ID 1864107, 14 pages, 2018. https://doi.org/10.1155/2018/1864107.